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ABSTRACT 
 Solid dispersions in water soluble carriers have attracted considerable interests as a mean of 
improving the dissolution rate & hence possibly bioavailability range of hydrophobic drugs. 
The poor solubility of ciprofloxacin leads to poor dissolution & hence variation in 
bioavailability. The purpose of present investigation was formulation & evaluation of 
controlled release floating capsule of ciprofloxacin with improved solubility & dissolution 
rate. In present study solid dispersion using various carriers like mannitol & lactose in 
different ratios were prepared by solvent evaporation method. The prepared solid dispersions 
were characterized for drug content, solubility & dissolution rate. The dissolution rate 
substantially improved for ciprofloxacin from its solid dispersions compared with pure drug. 
Dissolution rate increased with increase in carrier content. The dissolution rate was increased 
3 folds with solid dispersions containing 1:4 of drug: lactose. The granules of ciprofloxacin 
solid dispersion containing 1:4 of drug: lactose ratio was prepared by wet granulation method 
using polymer such as ethyl cellulose & HPMC. The prepared granules were evaluated to 
preformulation studies such as angle of repose (18.41-24.22), bulk density, tapped density, 
compressibility index (11.31-12.75) & hausner’s ratio. All the parameters shows that the 
granules having good flow properties. These granules had converted into the capsule forms. 
Then the formulated capsules were taken to the evaluation studies such as weight variation, 
release study, buoyancy & floating duration (more than 6 hrs.). We can conclude that all the 
parameters were within the acceptable limits. 
. 
  
Introduction 
Oral ingestion is the most convenient & commonly employed 
route of drug delivery due to its ease of administration, high 
patient compliance, cost effectiveness, least sterility 
constraints & flexibility in the design of dosage form. Poorly 
water soluble drugs often administration 
[1]
. Low aqueous 
solubility is the major problem encountered with formulation 
development of new chemical entities as well as generic 
development. The poor solubility & low dissolution rate of 
poorly water soluble drugs in the aqueous gastrointestinal 
fluids often cause insufficient bioavailability. Especially for 
class II (low solubility & high permeability) substances 
according to the BCS, the bioavailability may be enhanced by 
increasing the solubility & dissolution rate of the drug in the 
gastrointestinal fluids. As for BCS class II drugs rate limiting 
step is drug release from the dosage form & solubility in the 
gastric fluids & not the absorption, so increasing the solubility 
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in turn increases the bioavailability for BCS class II drugs
[3]
. A 
drug with poor bioavailability is the one with 
1. Slow dissolution rate & poor bioavailability in biological 
fluids. 
2. Poor permeation through biomembrane with inadequate 
partition coefficient. 
3. Poor stability of dissolved drug at physiological pH. 
4. Extensive presystemic metabolism. 
Few literature were comes up with improved solubility of 
some poorly water soluble drugs, 
1. Enhancement of dissolution profile of meloxicam using 
solid dispersion with various polymers. Solid dispersion 
was prepared by melting & solvent evaporation method. 
Dissolution studies were performed for plain meloxicam, 
SD’s & tablet formulations. Infrared spectroscopy & 
differential scanning calorimetry were performed to 
identify the physicochemical interaction between drug & 
carriers. 
2. Solid dispersion of furosemide in SSG was prepared in 
ratios of 1:1 & 1(furosemide): 2 (SSG) by kneading 
method. Dissolution studies indicated that the solid 
dispersion formulated in 1:2 ratios showed a 5.40-folds 
increase in dissolution & also exhibited superior 
dissolution characteristics to commercial furosemide 
tablets. 
3. Solid dispersions (SDs) of Aceclofenac were prepared 
using lactose, Mannitol & urea to increase its aqueous 
solubility. Aceclofenac solid diversions were prepared in 
9:1, 7:3 & 4:1 ratios of the drug to polymer (by weight). 
In Vitro release profiles of all SDs (F-1 to F-9) were 
comparatively evaluated & also studied against pure 
Aceclofenac. Faster dissolution was exhibited by solid 
dispersion containing 9:1 ratio of drug: lactose. The 
increase in dissolution rate of the drug may be due to 
increase in wettebility, hydrophilic nature of the carrier & 
due to reduction in drug crystallinity. 
The objective of the present study is to increase its dissolution 
profile by the solid dispersion technique. When a drug 
administrated orally it should have less rapid absorption for 
achieving consistent & complete therapeutic response.  For 
better therapeutic response the drug should be sufficiently & 
systemically bioavailable
 [1, 2, 3, 4]
. 
Material & methods 
Ciprofloxacin was obtained as a gift sample from Cipla Pvt. 
Ltd. (Goa, India). Mannitol, Lactose, Dichloromethane, 
Hydrochloric acid, Cetyl alcohol, Ethyl cellulose, HPMC, 
Sodium Bicarbonate, starch & Talc were procured from Pallav 
Chemicals, Mumbai. All materials used were of analytical 
grade. 
Method estimation 
Stock solution was prepared by dissolving 100 mg of 
accurately weighed ciprofloxacin in 100 ml of 
dichloromethane to get 1mg/ml solution. Further 10 ml of this 
solution was pipetted into 100 ml volumetric flask & made up 
to 100 ml with 0.1 N HCL to get 100 μg/ml solution. Further 
10 ml of this solution was pipetted into 100 ml of volumetric 
flask & made up to 100 ml with 0.1 N HCL to get 10 μg/ml 
solutions. From this 0.1, 0.2, 0.3, 0.4, 0.5 ml solutions were 
pipetted out into a series of 10 ml volumetric flask & were 
made up to 10 ml with 0.1 N HCL to get 1, 2, 3, 4 & 5 μg/ml 
solutions of ciprofloxacin respectively. The absorbance of 
resulting solution was at 277 nm 
[5]
 against the blank. 
Preliminary solubility study 
Solubility measurements of ciprofloxacin were performed 
according to published method 
[6]
. An excess amount of 
ciprofloxacin were added to 10 ml of aqueous solution of 
water soluble carriers like Mannitol & lactose in the various 
ratios such as 1:1, 1:2 & 1:4 in screw capped bottles. Samples 
were shaken in an orbital shaker for the 24 hrs at room 
temperature. Subsequently, the suspensions were filtered 
through a Whatman filter paper grade no. 1. Filtered solution 
diluted properly with distilled water. The diluted solution 
analyzed for the ciprofloxacin in UV 277 nm. 
Preparation of solid dispersion 
Table no. 1 Formulation plan of ciprofloxacin solid dispersion 
 
Sr. No. Formulation Composition Drug: Polymer Ratio 
1 SDM1 Ciprofloxacin: Mannitol 1:1 
2 SDM2 Ciprofloxacin: Mannitol 1:2 
3 SDM4 Ciprofloxacin: Mannitol 1:4 
4 SDL1 Ciprofloxacin: Lactose 1:1 
5 SDL2 Ciprofloxacin: Lactose 1:2 
6 SDL4 Ciprofloxacin: Lactose 1:4 
Solid dispersion is one of the most commonly used techniques 
to improve solubility of water insoluble drugs which in turn 
improves the bioavailability. Ciprofloxacin solid dispersions 
were prepared by using carriers (i. e. Mannitol & Lactose) in 
proportions VIZ. 1:1, 1:2 & 1:4 (drug: carrier) by solvent 
evaporation method. The drug & carrier was dissolved in 
dichloromethane & triturated in dry mortar until the solvent 
evaporated & a clear film of drug & carrier was obtained. The 
resultant solid dispersion was scrapped out with a spatula. 
Dispersions were pulverized in mortar & pestle & passed 
through a sieve no. 80. Then the prepared formulations were 
stored in desiccators until further use
 [7]
. 
 
Solid dispersion solubility study 
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Solubility measurements of ciprofloxacin were performed 
according to published method 
[10]
. Solid dispersion equivalent 
to 100 mg of ciprofloxacin were shaken with 10 ml distilled 
water in stoppered conical flask in an orbital shaker for 24 hrs 
at room temperature. Subsequently, the solutions were filtered 
through a Whatman filter paper no.1. Filtered solution was 
diluted properly with distilled water. The diluted solution was 
analyzed for the ciprofloxacin on UV spectrophotometer at 
277 nm. 
Evaluation of solid dispersion 
Drug content 
Solid dispersion equivalent to 10 mg of ciprofloxacin were 
weighed accurately & dissolved in the 10 ml of 
dichloromethane. The solution was filtered, diluted suitably & 
drug content was analyzed at 277 nm by UV 
spectrophotometer. The actual drug content was calculated 
using the following equation as follows; 
              (  )  
    
  
     
Mact= Actual amount of drug in solid dispersion 
Mt= Theoretical amount of drug in sold dispersion  
Determination of flow properties 
Bulk density & tapped density 
Accurately weighed amount of solid dispersions were 
transferred to 100 ml of graduated cylinder to measure the 
apparent volume of bulk volume (Vb). The measuring cylinder 
was tapped for a fixed period of time & tapped volume (Vt) 
occupied in the cylinder was measured. The bulk density & 
tapped/true density were calculated in grams /milliliter by the 
following formula: 
             (  )                   
               (  )  
    
             
      
Carr’s Index (CI) & Hausner’s ratio (HR) 
Carr’s index & Hausner’s ratio are calculated by using 
following formulae 
[11, 12]
. 
    
(                           )
              
      
       ’        
              
            
 
Angle of repose 
A funnel was fixed in the stand in such a way that the top of 
the funnel was at the height of 6 cm from the surface. The 
solid dispersions were passed from the funnel was at height of 
6 cm from the surface. The height & radius of the heap were 
measured & the angle of repose was calculated using the 
equation 
[13]
.  
        
( 
 ⁄ ) 
h = Height of heap 
r = Radius of the heap 
In Vitro release study 
In vitro dissolution studies 
[14] 
were performed for prepared 
solid dispersion. The following conditions were maintained 
for the dissolution process: 
1. Equipment: dissolution test apparatus 
2. Apparatus: Paddle type 
3. Temperature: 37±0.5° C 
4. RPM: 50 
5. Dissolution medium: 0.1 N HCL 
6. Volume of medium: 900 ml 
7. Sampling intervals: 5, 10, 15, 20, 30 45, 60, 90 
minutes 
8. Sample volume: 5 ml withdrawn & replaced with 5 
ml of 0.1 N HCL 
Preparation of granules 
Ciprofloxacin solid dispersions, Ethyl cellulose, HPMC, Cetyl 
alcohol & sodium bicarbonate were weighed by electronic 
balance & mixed well in m mortar. Required amount of starch 
was taken in a beaker. Small amount of water was taken init & 
stirred well until thick paste was formed without limps. Excess 
water was boiled in a separate beaker for 15 minutes 7 then 
add to the paste while stirring to form a mucilage. The 
mucilage was slowly added to the powder mix to form a damp 
mass that breaks with a snap when pressed between thumb & 
index finger. The damp mass was passed through the sieve & 
the granules were collected on dry tray. The granules were 
dried in hot air overate 60 °C for 2 hrs. Then the dried 
granules were passed through sieve. The granules were filled 
in empty gelatin capsules shell by hand filling capsules 
machine. The compositions of different ratios of floating 
capsules with different carriers are given in following tables 
[8, 
9]
. 
Evaluation of granules flow characteristics 
[15, 16, 17]
 
Bulk density 
A known quantity of granules was poured into the measuring 
cylinder carefully level the granules without compacting, if 
necessary & read the unsettled apparent volume (V), to the 
nearest graduated unit. Calculate the bulk density, in gm per 
ml, by the formula m/v. 
Tapped density 
A known quantity of granules were taken in a measuring 
cylinder & tapped on mechanical tapping apparatus for 5 
minutes. The initial 7 final volumes were noted. 
               
                    
                           
 
Angle of repose 
The frictional forces in a loose powder or granules can be 
measured by angle of repose. This is maximum angle possible 
between the surface of pile of powder or granules & the 
horizontal plane. The value of angle of repose are calculated 
by using the following formula,  
     
 
 
 
        
 
 
 
Where,   = angle of repose, h = Height of heap & r = Radius 
of heap 
 
Compressibility index & hausner’s ratio 
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The compressibility index 7 closely related hausner’s ratio has become the simple, fast & popular method of predicting granules flow 
characteristics. The compressibility index & hausner’s ratio were determined both the bulk density & tapped density of granules. 
                                                                                                           
     
  
     
                                                                                                   
                
  
  
 
 
Composition of solid dispersion capsules 
Table no. 2 composition of ciprofloxacin solid dispersion controlled release floating capsules 
 
Ingredients F1 F2 F3 F4 F5 F6 
Solid dispersion equivalent to 
ciprofloxacin 
100 100 100 100 100 100 
Cetyl alcohol q. s… q. s… q. s… q. s… q. s… q. s… 
Ethyl cellulose 125 100 75 50 25 - 
HPMC - 25 50 75 100 125 
Starch 15 15 15 15 15 15 
Sodium bicarbonate 25 25 25 25 25 25 
Talc 2.5 2.5 2.5 2.5 2.5 2.5 
Evaluation of capsules 
Weight variation 
[9, 15]
 
Twenty capsules were randomly selected & individually 
weighed. The average weight of capsules were calculated & 
compared with individual weight. 
 
Determination of In-Vitro dissolution study 
[18] 
Dissolution study was carried out in USP- II type dissolution 
apparatus (paddle type). Dissolution study was performed at 
50 rpm in 900 ml 0.1 N HCL 5ml of sample was withdrawn at 
predetermined intervals & the volume of dissolution medium 
was maintained by adding same volume of dissolution 
medium. Absorbance of these solutions was measured using 
UV visible spectrophotometer. 
Floating capacity 
[8, 19]
 
Floating characteristics of the prepared formulations were 
determined by using USP- II paddle type apparatus at a paddle 
speed of 50 rpm in 900 ml of a 0.1 N HCL solution (pH= 1.2) 
at 37 ± 0.5°C for 12 hrs. The time between introduction of 
capsule & its buoyancy on the simulated gastric fluid (floating 
time) & the time during which the dosage form remains 
buoyant (floating duration) were measured. 
Result & discussion 
Method of estimation  
Ciprofloxacin was estimated by UV spectrophotometer 
method by measuring the absorbance at 277 nm. The method 
was validated for linearity, accuracy, precision & interference. 
The method obeyed Beers law in the concentration range of 1-
5 µg/ml (R
2
=0.997).  
 
Figure no. 1 Calibration curve of ciprofloxacin in 0.1 N HCL 
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Preliminary solubility study 
Table no. 3 Preliminary solubility studies of drug 
 
Sr. no. Drug: carrier Solubility (µg/ml) 
1 Pure drug 4.7 
2 Ciprofloxacin + Mannitol 9.57 
3 Ciprofloxacin + Mannitol 11.41 
4 Ciprofloxacin + Mannitol 14.53 
5 Ciprofloxacin + Lactose 20.51 
6 Ciprofloxacin + Lactose 27.23 
7 Ciprofloxacin + Lactose 31.89 
In case of solid dispersions initially preliminary solubility 
analysis were carried out to select the appropriate water 
soluble carriers for the preparation of solid dispersion in which 
pure drug solubility found to be 4.7 mcg/ml.From this 
Mannitol and Lactose in the ratio of 1:1, 1:2, 1:4 was selected 
for the preparation of the solid dispersion. Complete 
composition of six formulations showed. The preliminary 
solubility study of ciprofloxacin was carried out for pure form 
as well as for drug: carrier mixture forms as shown in table no. 
8.1. The solubility of pure ciprofloxacin was found to be 4.7 
mg/ml. The preliminary solubility for drug: mannitol ratios 
1:1, 1:2, 1:4 was observed 9.57 mg/ml, 11.41 mg/ml and 14.53 
mg/ml respectively. On another hand, drug: lactose ratios 1:1, 
1:2, 1:4 respectively showed 20.51 mg/ml, 27.23 mg/ml, 31.89 
mg/ml preliminary solubility. The drug: lactose ratio 1:4 
showed higher solubility as compared to drug: mannitol ratio 
1:4 as showed in figure no. 2. 
 
Figure no. 2 Preliminary solubility studies of ciprofloxacin (On X axis: 1. PD; 2. Ciprofloxacin + Mannitol (1:1); 3. 
Ciprofloxacin + Mannitol (1:2); 4. Ciprofloxacin + Mannitol (1:4); 5. Ciprofloxacin + Lactose (1:1); 6. Ciprofloxacin + Lactose 
(1:2); 7. Ciprofloxacin + Lactose (1:4) 
Solid dispersion solubility study  
Solid dispersions were prepared by solvent evaporation 
method with their respective carriers. All the SDs prepared 
was found to be fine and free flowing powders. After 
preparation of solid dispersion solubility analysis were carried 
out and compared with pure drug. The formulation with 
Lactose in the ratio of 1:4 (drug to carrier) which had 
increased the solubility almost 8 fold compared to that of pure 
drug. The solid dispersion solubility study of ciprofloxacin 
was carried out as showed in table no. 8.2.The solid dispersion 
solubility for SDM1, SDM2, SDM4, SDL1, SDL2, and SDL4 
was found to be 12.52 mg/ml, 13.71 mg/ml, 17.67 mg/ml, 
29.01 mg/ml, 34.23 mg/ml, and 42.61 mg/ml respectively. The 
SDL4 showed higher solubility as compared to SDM4 as 
showed in figure no. 3. 
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Table no. 4 solubility studies of ciprofloxacin solid dispersions 
Sr. no. Drug: carrier Solubility (µg/ml) 
1 SDM1 12.52 
2 SDM2 13.71 
3 
SDM4 
17.67 
4 
SDL1 
29.01 
5 
SDL2 
34.23 
6 
SDL4 
42.61 
 
Figure no. 3 Solubility studies of ciprofloxacin solid dispersions (On X axis: 1.SDM1; 2.SDM2; 3.SDM4; 4.SDL1; 5.SDL2; 
6.SDL4) 
Micromeritic & morphological study of solid dispersions 
Table no. 5 Drug content, Micromeritics properties, Solubility & Dissolution efficiency of ciprofloxacin & its solid dispersion
 
Sample Drug content (%) Carr’s index Hausner’s ratio Angle of repose (°) Aqueous solubility (µg/ml) 
Pure drug 100 38.37 1.62 45 4.7 
SDM1 
95.54 16.77 1.201 30.32 12.52 
SDM2 93.02 16.62 1.199 29.72 13.71 
SDM4 92.08 16.52 1.197 29.51 17.67 
SDL1 96.89 16.19 1.193 29.68 29.01 
SDL2 94.02 14.33 1.167 29.24 34.23 
SDL4 92.72 13.98 1.162 28.59 42.61 
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Flowability of ciprofloxacin (pure drug) & its solid dispersion 
was assessed by determination of Carr’s index (CI), Hausner’s 
ratio & angle of repose. Micromeritic behavior of the 
untreated ciprofloxacin powder & all prepared solid 
dispersions are listed. Table no. 5 shows that the flowability 
represented in terms of Carr’s index, Hausner’s ratio & angle 
of repose was much improved compared to those of original 
powders (untreated ciprofloxacin). In case of pure 
ciprofloxacin powder could not pass through the funnel during 
the angle of repose experiment. The poor flow of 
ciprofloxacin could be due to the irregular shape & high 
fitness of the powder, which posed hurdles in the uniform flow 
from the funnel. These results are significantly different from 
those of untreated ciprofloxacin. Actual drug content of al 6 
formulations are shown in table no. 5. The drug content of 
prepared SD’s was found to be in range of 92.08 to 96.89 %. 
 
In Vitro dissolution study of solid dispersion  
Table no.6 Cumulative % drug release of ciprofloxacin solid dispersion 
 
Time (Min) PD SDM1 SDM2 SDM4 SDL1 SDL2 SDL4 
5 2.77 18.96 27.53 38.53 51.56 63.68 77.63 
10 4.94 39.65 46.23 51.56 62.50 75.12 82.41 
15 9.80 52.89 61.28 69.87 71.23 84.39 87.35 
20 14.54 69.14 76.96 73.20 80.23 87.22 92.96 
30 22.60 80.61 82.52 84.37 88.91 93.76 97.07 
45 30.20 84.23 87.85 89.23 91.52 96.78 98.68 
60 36.56 87.85 91.23 92.56 97.05 97.21 --- 
90 42.21 90.84 93.96 96.97 95.03 --- --- 
The dissolution rate study was carried out for pure ciprofloxacin as well as for ciprofloxacin solid dispersions. The cumulative % drug 
release has showed in table no. 6.The % drug release of pure form was found to be 42.21 % at 90 minutes. The SDM4 showed 98.97 
% drug release at 90 minutes as showed in figure no. 4. The SDL4 showed 99.68 % drug release at 45 minutes as showed in figure no. 
5. On another hand, the SDL4 showed 99.68 % drug release at 45 minutes, which is higher than % drug release of SDM4. 
 
Figure no.4 Cumulative % drug dissolved Vs time plots of ciprofloxacin solid dispersion containing mannitol 
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Figure no.5 Cumulative % drug dissolved Vs time plots of ciprofloxacin solid dispersion containing lactose
Evaluation of solid dispersion granules  
Micromeritic & morphological study of solid dispersion 
granules 
In the present investigation, ciprofloxacin controlled release 
floating capsules were prepared by using polymers such as 
ethyl cellulose (EC) & HPMC. A total number of 6 
formulations were prepared by wet granulation method. Angle 
of repose for F1-F6 is between 18.41° to 24.22°, bulk density 
is in between 0.442-0.450, compressibility index is in between 
11.235-12.751 & Hausner’s ratio is in between 1.126-1.146 
are within the acceptable limits (Table no.7). The above values 
of pre compression parameters show the prepared granules 
having good flow property. From the preformulation studies 
for drug excipients compatibility, it was observed that no 
physical incompatibility existed between the drug & 
excipients. The weight variation was within ±5 %, it was 
within the acceptable limit.  
 
 
 
Table no. 7 Evaluation of ciprofloxacin + Lactose solid dispersion granules (Ratio = 1:4) 
Formulation Angle of repose Bulk density Tapped density Compressibility index 
(%) 
Hausner’s ratio 
F1 18.41 0.392 0.442 11.312 1.127 
F2 23.19 0.395 0.445 11.235 1.126 
F3 17.35 0.390 0.447 12.751 1.146 
F4 20.22 0.393 0.444 11.486 1.129 
F5 22.30 0.395 0.449 11.026 1.136 
F6 24.22 0.395 0.450 11.555 1.130 
Table no. 8 Evaluation of ciprofloxacin + Lactose solid dispersion capsules (Ratio = 1:4) 
Formulation Buoyancy lag time (Sec) Floating duration (hrs) 
F1 27 >6 
F2 48 >6 
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F3 51 >6 
F4 36 >6 
F5 45 >6 
F6 58 >6 
 
The floating duration was greater than 6 hrs in F1-F6 (Table no. 8). The formulation F6 showed higher buoyancy lag time as well as 
floating duration than others as showed in table no. 8. 
In Vitro dissolution study of formulated capsules 
In-vitro drug release showed (Figure no. 6) that the variation 
of release pattern of different batches (F1-F6) of the 
ciprofloxacin in 6 hrs study period. In-Vitro dissolution study 
was carried out for ciprofloxacin solid dispersion controlled 
release floating capsules. The % drug release has showed in 
table no. 9. The F6 showed 53.86 % drug release at 360 
minutes, which is higher than % drug release of others. 
Formulation F6 showed higher solubility profile. 
Table no. 9 In Vitro dissolution study of ciprofloxacin + Lactose solid dispersion capsules (Ratio = 1:4) 
Time (Min) F1 F2 F3 F4 F5 F6 
60 21.01 22.86 24.56 27.86 29.32 31.58 
120 22.56 24.86 28.96 30.45 32.56 36.34 
180 24.81 27.61 31.56 35.68 37.96 43.08 
240 26.56 29.76 35.07 39.05 42.63 46.89 
300 28.82 31.45 36.89 41.56 46.03 49.89 
360 29.98 34.89 39.91 45.63 49.05 53.86 
 
 
Figure no. 6 In Vitro dissolution study of formulated capsules 
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Solid dispersions prepared by hydrophilic polymers like 
mannitol & lactose using the solvent evaporation technique 
was effective in improving drug dissolution. These solid 
dispersions were analyzed for solubility & in vitro dissolution 
profile. Dissolution of drug increase with an increase in carrier 
content. Solid dispersions prepared with lactose had shown 
enhanced solubility with improved dissolution rate. Controlled 
release floating capsules of ciprofloxacin & different carriers 
can enhance the gastric residence time as well as 
bioavailability & better patient compliance can be achieved. 
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